Litcius/Paper detail

Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistry

Laura Scalvini, Riccardo Castelli, Silvia La Monica, Marcello Tiseo, Roberta Alfieri

2021Biochemical Pharmacology25 citationsDOI

Topics & Concepts

OsimertinibEpidermal growth factor receptorLung cancerEGFR inhibitorsPoint mutationCancer researchMutationMedicineBiologyCancerOncologyErlotinibInternal medicineGeneGeneticsLung Cancer Treatments and MutationsCancer therapeutics and mechanismsPI3K/AKT/mTOR signaling in cancer
Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistry | Litcius